Craniofacial Changes Among Children and Adolescents Submitted to Growth Hormone Therapy: A Systematic Review

Raul Borges Nascimento1, Suelly Maria Mendes Ribeiro2, Nathalia Carolina Fernandes Fagundes2

  • 1Faculty of Dentistry, Federal University of Pará, Belém, Brazil.

Insights

Growth hormone (GH) therapy in children with GH deficiency or idiopathic short stature (ISS) showed a small, clinically insignificant increase in mandibular dimensions. More long-term studies are needed to confirm effects on craniofacial growth.

Area of Science:

  • Pediatric Endocrinology
  • Craniofacial Biology
  • Systematic Review Methodology

Background:

  • Growth hormone (GH) therapy is used for children with GH deficiency or idiopathic short stature (ISS).
  • Understanding the impact of GH therapy on craniofacial development is crucial for monitoring treatment outcomes.
  • Previous research has yielded varied results regarding craniofacial changes during GH therapy.

Purpose of the Study:

  • To systematically review the association between craniofacial changes and GH therapy in pediatric populations with GH deficiency or ISS.
  • To synthesize evidence on the effects of GH therapy on cephalometric measurements and dental age.
  • To assess the risk of bias and certainty of evidence for included studies.

Main Methods:

  • Systematic review adhering to PRISMA guidelines.
  • Electronic search across seven databases without year or language restrictions.
  • Inclusion of studies on craniofacial changes in children/adolescents receiving GH therapy; risk of bias and evidence certainty assessed using JBI, RoB 2.0, and GRADE tools.

Main Results:

  • Seven studies met eligibility criteria from 4494 identified citations.
  • GH therapy showed a small, clinically insignificant increase in mandibular dimensions.
  • No significant differences were found in maxillary and mandibular dimensions between immediate and delayed treatments.
  • Low risk of bias and low certainty of evidence were observed across all outcomes.

Conclusions:

  • GH therapy may lead to a slight increase in mandibular and maxillary dimensions without significant adverse health effects.
  • Current evidence suggests minimal clinical impact on craniofacial growth.
  • Further controlled intervention studies with long-term follow-up are necessary to establish precise recommendations.

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
148
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.3K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.5K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.3K
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
257
Sutures of the Skull01:22

Sutures of the Skull

The human skull is composed of several bones that come together to protect the brain and support the structures of the face. The junctions where these bones meet are called sutures.
Sutures are immobile joints between adjacent bones of the skull. The narrow gap between the bones is filled with dense, fibrous connective tissue that unites the bones. The long sutures located between the skull bones are not straight but instead follow irregular, tightly twisting paths. These twisting lines tightly...
5.8K